2022
DOI: 10.1016/j.bioorg.2021.105506
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure–activity relationship studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(8 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…The microbiology lab at NMSRC (Natural and Medical Sciences Research Center) at the University of Nizwa in Oman provided all the organisms for this investigation. Each extract was evaluated in Dimethyl Sulfoxide (DMSO) at four distinct concentrations: 125, 250, 500 and 1000 µg mLG 1 . By immersing filter paper discs (5 mm) in vials holding the prepared solutions, extracts were impregnated.…”
Section: Antibacterial Activity Using Disc Diffusion Methodmentioning
confidence: 99%
See 2 more Smart Citations
“…The microbiology lab at NMSRC (Natural and Medical Sciences Research Center) at the University of Nizwa in Oman provided all the organisms for this investigation. Each extract was evaluated in Dimethyl Sulfoxide (DMSO) at four distinct concentrations: 125, 250, 500 and 1000 µg mLG 1 . By immersing filter paper discs (5 mm) in vials holding the prepared solutions, extracts were impregnated.…”
Section: Antibacterial Activity Using Disc Diffusion Methodmentioning
confidence: 99%
“…Type 2 diabetes is one of the main metabolic illnesses, which is brought on by insufficient insulin production, diminished insulin activity or both 1 . Leading long-term consequences of diabetes, obesity, metastatic cancer and cardiovascular disorders are all correlated with persistent hyperglycaemia 2 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, the inhibition of α-glucosidase might reduce carbohydrate digestion, delay glucose uptake, and consequently, decrease blood sugar levels 14 , 15 . The α-glucosidase enzyme can be inhibited by acarbose, voglibose, and miglitol with sub-optimal efficacy 16 . Also, long-term administration of mentioned inhibitor may cause several side effects, such as abdominal pain, diarrhea, and flatulence.…”
Section: Introductionmentioning
confidence: 99%
“…Inhibition of the α-glucosidase can limit the digestion of carbohydrates resulting in declined postprandial blood sugar levels [12]. As a result, α-glucosidase inhibitors (AGIs) can be used as first-line therapy for T2DM [13][14][15].…”
Section: Introductionmentioning
confidence: 99%